Return to search

Antibacterial and antimycobacterial activities of South African Salvia species and isolated compounds from S. chamelaeagnea

Extracts of 16 South African Salvia species commonly used in traditional medicine to treat various microbial infections were investigated
for in vitro antibacterial and antimycobacterial activities using the micro-dilution and respiratory BACTEC method, respectively. The microorganisms
tested include two Gram-positive (Staphylococcus aureus and Bacillus cereus); two Gram-negative (Escherichia coli and Klebsiella
pneumoniae) bacterial strains and the common pathogen responsible for tuberculosis, Mycobacterium tuberculosis. Extracts of the
majority of species exhibited moderate to good antibacterial activity with minimum inhibitory concentration (MIC) values ranging from 0.03 to
8.00 mg/ml. Promising activity was observed against M. tuberculosis (MIC≤0.50 mg/ml) with S. radula, S. verbenaca and S. dolomitica
displaying the most favourable activity (MIC: 0.10 mg/ml). The antibacterial bioassay-guided fractionation of S. chamelaeagnea resulted in
the isolation of four compounds: carnosol, 7-O-methylepirosmanol, oleanolic acid and its isomer ursolic acid as the active principles against
S. aureus. The in vitro antibacterial and antimycobacterial activities may support the use of Salvia species in traditional medicine to treat
microbial infections.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:tut/oai:encore.tut.ac.za:d1000837
Date13 March 2007
CreatorsKamatou, GPP, Van Vuuren, SF, Van Heerden, FR, Seaman, T, Viljoen, AM
PublisherElsevier
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
TypeText
FormatPdf
Rights© 2007 SAAB
RelationSouth African Journal of Botany

Page generated in 0.0017 seconds